Article
Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients.
Pharmacogenomics - 1 Jul 2007
Nakai Kenji, Tsuboi Jyunichi, Okabayashi Hitoshi, Fukuhiro Yoshiaki, Oka Takanori, Habano Wataru, Fukushima Noriko, Nakai Keiko, Obara Wataru, Fujioka Tomoaki, Suwabe Akira, Gurwitz David
Abstract excerpt
OBJECTIVES: Vitamin K epoxide reductase (VKORC1) is the drug target for inhibition by coumarin-based anticoagulant drugs such as warfarin. Warfarin therapy has been reported as a leading cause of drug-related hospitalization and there is therefore an urgent need to develop tests for better warfarin prescription. We report here the distribution of the intron 1 -136 T>C (1173 T>C intron) polymorphism of VKORC1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
